Literature DB >> 21289510

Impaired fasting glucose association with mortality in nondiabetic patients on maintenance peritoneal dialysis.

Kuan-Hsing Chen1, Ja-Liang Lin, Cheng-Chieh Hung, Dan-Tzu Lin-Tan, Shu-Man Weng, Tzung-Hai Yen, Ching-Wei Hsu, Chih-Wei Yang.   

Abstract

INTRODUCTION: The aim of this study was to investigate clinical significance of impaired fasting glucose (IFG) in nondiabetic patients on maintenance peritoneal dialysis (PD).
METHODS: In total, 362 maintenance PD patients were enrolled and followed up for 2-years. According to 1997 definitions, patients were divided into 3 groups: diabetic (n = 85), nondiabetic with IFG (n = 62) and nondiabetic with normal fasting glucose levels (n = 215). After basal data were collected for cross-sectional analyses, mortality and cause of death were recorded for longitudinal analyses.
RESULTS: After adjusting for related variables by multivariate logistic regression analysis, IFG was found to be positively associated with age but negatively associated with normalized protein nitrogen appearance and transferrin saturation in nondiabetic maintenance PD patients. Thirty nondiabetic patients had died after the 2-year follow-up. Cox multivariate analysis showed that age (hazard ratio: 1.037; 95% confidence interval: 1.002-1.073; P = 0.036) and presence of IFG (hazard ratio: 2.719; 95% confidence interval: 1.082-6.833; P = 0.033) were significant risk factors for all-cause 2-year mortality in nondiabetic maintenance PD patients.
CONCLUSIONS: IFG, a preventable and treatable condition, was associated with all-cause 2-year mortality in nondiabetic maintenance PD patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289510     DOI: 10.1097/MAJ.0b013e318203745b

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  High blood glucose independent of pre-existing diabetic status predicts mortality in patients initiating peritoneal dialysis therapy.

Authors:  Sung Hee Chung; Dong Cheol Han; Hyunjin Noh; Jin Seok Jeon; Soon Hyo Kwon; Bengt Lindholm; Hi Bahl Lee
Journal:  Int Urol Nephrol       Date:  2015-04-28       Impact factor: 2.370

Review 2.  Peritoneal dialysis--current status and future challenges.

Authors:  Simon J Davies
Journal:  Nat Rev Nephrol       Date:  2013-05-21       Impact factor: 28.314

3.  Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.

Authors:  Nigar Sekercioglu; Chrysostomos Dimitriadis; Chrysoula Pipili; Rosilene Motta Elias; Joseph Kim; Dimitrios G Oreopoulos; Joanne M Bargman
Journal:  Int Urol Nephrol       Date:  2012-05-12       Impact factor: 2.370

4.  Environmental NO2 level is associated with 2-year mortality in patients undergoing peritoneal dialysis.

Authors:  Jui-Hsiang Lin; Tzung-Hai Yen; Cheng-Hao Weng; Wen-Hung Huang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

5.  Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009-2013).

Authors:  Seung Eun Lee; Kyungdo Han; Yu Mi Kang; Seon-Ok Kim; Yun Kyung Cho; Kyung Soo Ko; Joong-Yeol Park; Ki-Up Lee; Eun Hee Koh
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

6.  Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment.

Authors:  Yanan Shi; Jiajie Cai; Chunxia Shi; Conghui Liu; Jingjing Zhou; Zhongxin Li
Journal:  J Healthc Eng       Date:  2022-04-18       Impact factor: 3.822

7.  Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis.

Authors:  Chang-Yun Yoon; Mi Jung Lee; Youn Kyung Kee; Eunyoung Lee; Young Su Joo; In Mee Han; Seung Gyu Han; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo
Journal:  Kidney Res Clin Pract       Date:  2014-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.